MESO
Mesoblast Limited
NASDAQ · Healthcare · Biotechnology · AU
$17.32
+1.05%Leverage
- Debt / equity
- 0.22x
- Net debt / equity
- 0.04x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -2.83x
- Net debt / EBITDA
- -0.54x
Liquidity & coverage
- Current ratio
- 2.43x
- Quick ratio
- 2.09x
- Cash ratio
- 1.27x
- Interest coverage
- -10.46x
- EBITDA / interest
- -3.99x
- Working capital
- $116.4M
Cash & dividend
- FCF / debt
- -0.33x
- Cash flow / debt
- -0.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026